Table 2.
Glaucoma nonvisual symptoms scale (GSS-SYMP-6) measurements
| Visits | N | Mean (SD) |
95% CI |
P-values | |
|---|---|---|---|---|---|
| Lower limit | Upper limit | ||||
| Baseline (week 0) | 122a | 73.6 (21.8) | 69.5 | 77.1 | – |
| Week 4 | 115b | 74.5 (19.3) | 71.1 | 78.1 | – |
| Absolute change from baseline | 114c | 1.8 (16.9) | −1.3 | 4.9 | 0.260 |
| Week 8 | 113d | 76.1 (20.7) | 72.3 | 79.7 | – |
| Absolute change from baseline | 111e | 3.2 (20.2) | −0.6 | 7.0 | 0.097 |
Notes:
a
The GSS-SYMP-6 was not completed for both eyes at baseline by 56 of the 178 patients.
b
The GSS-SYMP-6 was not completed for both eyes at week 4 by 54 of the 169 patients.
c
The GSS-SYMP-6 was not completed for both eyes at baseline and week 4 by 55 of the 169 patients.
d
The GSS-SYMP-6 was not completed for both eyes at week 8 by 63 of the 176 patients.
e
The GSS-SYMP-6 was not completed for both eyes at baseline and week 8 by 65 of the 176 patients.
Abbreviation: CI, confidence interval.